PCM
OCEA

Pinz Capital Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Pinz Capital Management’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-60,000
Closed -$607K – 190
2022
Q2 		$607K Hold
60,000
– – 0.42% 79
2022
Q1 		$605K Hold
60,000
– – 0.38% 81
2021
Q4 		$599K Buy
+60,000
New +$599K 0.23% 119

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Pinz Capital Management's OCEA Position: Q3 2022 in Review

Pinz Capital Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q3 2022, closing a stake of 60,000 shares — an estimated $607K sold.

Pinz Capital Management first reported a position in OCEA in Q4 2021 and held it in 3 quarters. The position peaked at $607K in Q2 2022. 40 funds tracked by Wall St. Rank hold OCEA as of Q3 2022.

  • Pinz Capital Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Pinz Capital Management sold 60,000 Ocean Biomedical, Inc. Common Stock shares in Q3 2022, an estimated $607K.
  • Pinz Capital Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Pinz Capital Management's Ocean Biomedical, Inc. Common Stock position peaked at $607K in Q2 2022.
  • 40 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q3 2022.

Based on Pinz Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.